Attar discusses the medication pipeline, possible AI implementation, and the importance of making patients aware of clinical trials for rare genetic diseases.
Roya Attar, OD
Advertisement
Articles by Roya Attar, OD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
New Injectable Substantially Reduces Visceral Adipose Tissue in Obesity
2
Remibrutinib Receives FDA Approval for Symptomatic Dermographism
3
RELIEVE-AD-PEDs: Dupilumab Sustains Adolescent Atopic Dermatitis Control at 1 Year
4
Top Reason for Leaving HAE Attacks Untreated, Survey Finds
5